Envestnet Asset Management
ANIX icon

Envestnet Asset Management’s Anixa Biosciences ANIX Stock Holding History

Envestnet Asset Management’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,700
Closed -$75K – 3270
2020
Q3 		$75K Buy
+30,700
New +$79.2K ﹤0.01% 3035

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Envestnet Asset Management's ANIX Position: Q4 2020 in Review

Envestnet Asset Management sold out of Anixa Biosciences (ANIX) in Q4 2020, closing a stake of 30,700 shares — an estimated $75K sold.

Envestnet Asset Management first reported a position in ANIX in Q3 2020 and held it in 1 quarter. The position peaked at $75K in Q3 2020. 22 funds tracked by Wall St. Rank hold ANIX as of Q4 2020.

  • Envestnet Asset Management reported no remaining Anixa Biosciences position as of Q4 2020 after selling out during the quarter.
  • Envestnet Asset Management sold 30,700 Anixa Biosciences shares in Q4 2020, an estimated $75K.
  • Envestnet Asset Management first reported a position in Anixa Biosciences in Q3 2020 and held it in 1 quarter.
  • Envestnet Asset Management's Anixa Biosciences position peaked at $75K in Q3 2020.
  • 22 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2020.

Based on Envestnet Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.